Back
Neuronetics 10K Form
Sell
38
STIM
Neuronetics
Last Price:
$4.52
Seasonality Move:
-25.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | STIM/Neuronetics Quarterly |
2023-11-07 | 10Q | STIM/Neuronetics Quarterly |
2023-08-08 | 10Q | STIM/Neuronetics Quarterly |
2023-05-15 | 10Q | STIM/Neuronetics Quarterly |
2022-11-08 | 10Q | STIM/Neuronetics Quarterly |
2022-08-02 | 10Q | STIM/Neuronetics Quarterly |
Receive STIM News And Ratings
See the #1 stock for the next 7 days that we like better than STIM
STIM Financial Statistics
Sales & Book Value
Annual Sales: | $74.9M |
---|---|
Cash Flow: | $-8.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.51 |
Price / Book: | 10.4 |
Profitability
EPS (TTM): | -1.37000 |
---|---|
Net Income (TTM): | $-43.2M |
Gross Margin: | $54.2M |
Return on Equity: | -188.28% |
Return on Assets: | -41.22% |
Neuronetics Earnings Forecast
Key Neuronetics Financial Ratios
-
The Gross Profit Margin over the past 10 years for STIM is 72.32%.
-
The Selling, General & Administrative Expenses for STIM have been equal to 100.72% of Gross Profit Margin.
-
The Research & Development expenses have been 17.05% of Revenue.
-
The Net Earning history of STIM is -57.69% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Neuronetics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | STIM |
CUSIP: | 64131A |
Website: | neurostar.com |
Debt
Debt-to-Equity Ratio: | 1.96 |
---|---|
Current Ratio: | 1.85 |
Quick Ratio: | 1.36 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
STIM Technical Analysis vs Fundamental Analysis
Sell
38
Neuronetics (STIM)
is a Sell
Is Neuronetics a Buy or a Sell?
-
Neuronetics stock is rated a SellThe current Neuronetics [STIM] share price is $4.52. The Score for STIM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.